Zobrazeno 1 - 10
of 47
pro vyhledávání: '"D S Rigel"'
Publikováno v:
Skin therapy letter. 23(5)
The Pigmented Lesion Assay (PLA) is a gene expression test that helps rule out melanoma and has the potential to reduce the need for surgical biopsies of atypical pigmented skin lesions. Utilizing a new technological platform for the non-invasive pro
Autor:
T. Rosen, M. S. Nestor, K. Boltz, D. A. Glaser, D. S. Rigel, R. S. Kirsner, N. D. Bhatia, L. F. S. Gold
Publikováno v:
MD Conference Express. 15:26-29
Publikováno v:
British Journal of Dermatology. 135:704-711
The classic atypical-mole syndrome (CAMS) and/or a history of malignant melanoma (MM) increases the risk for multiple melanomas. Case notes of 118 CAMS and 173 control patients, each with a history of MM, were reviewed for the occurrence of second pr
Autor:
A F Vinokur, R. J. Friedman, D S Rigel, E. R. Heilman, Jason K. Rivers, Alfred W. Kopf, Marcia J. Levenstein
Publikováno v:
Cancer. 65:1232-1236
A total of 452 patients with dysplastic nevi (DN) were followed prospectively by repetitive, complete cutaneous examinations in order to determine the clinical features of early malignant melanomas (MM) arising in them. Sixteen patients (3.5%) develo
Autor:
D S Rigel
Publikováno v:
The British journal of dermatology. 146
Autor:
S, Sahin, B, Rao, A W, Kopf, E, Lee, D S, Rigel, R, Nossa, I J, Rahman, H, Wortzel, A A, Marghoob, R S, Bart
Publikováno v:
Cancer. 80(8)
Recently, the Pigmented Lesion Group at the University of Pennsylvania described a 4-variable model for predicting 10-year survival for patients with primary cutaneous melanoma. The variables are tumor thickness, anatomic site of the lesion, age, and
Publikováno v:
Cancer. 75
The incidence of malignant melanoma is increasing rapidly. The risk for development of malignant melanoma has been reported to be higher in persons of higher socioeconomic status.This case-control study explores the relation between occupation and ma
Autor:
D S, Rigel
Publikováno v:
Advances in dermatology. 10
Multiple factors have been identified to be associated with increasing risk for MM developing. These factors are summarized in Table 2. As the incidence of MM continues to rise and the magnitude of this problem becomes more significant, the issue of
Publikováno v:
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer. 139
The presence of atypical moles (AM) is considered to be a marker for an increased risk of developing cutaneous malignant melanoma (MM). The extent to which individuals with the atypical-mole syndrome (AMS) are at risk for developing MM is unknown. We
Autor:
A A, Marghoob, A W, Kopf, D S, Rigel, R S, Bart, R J, Friedman, S, Yadav, M, Abadir, L, Sanfilippo, M K, Silverman, K A, Vossaert
Publikováno v:
Archives of dermatology. 130(8)
There is an increased risk of developing cutaneous malignant melanomas (MMs) in patients with classic atypical-mole syndrome (AMS). This study compares the incidence of newly diagnosed MMs in patients with classic AMS (cases) with the incidence of ne